Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 7 of the 66 sources its claims cite were checked for support.
Abstract
Background: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical characteristics. Methods: German individuals completed an online self-report survey of appearance concerns. A sample of N = 429 individuals met criteria for BDD. We examined the frequency of treatment utilization and barriers, analyzed comparisons between treated and untreated individuals and assessed the relationships of socio-demographic and clinical features with mental health treatment utilization and treatment barriers, respectively. Results: Only 15.2% of the individuals with BDD had been diagnosed with BDD, and lifetime rates of mental health treatment were low (39.9%). Individuals endorsed multiple barriers to mental health treatment, especially shame, low perceived need and a preference for cosmetic and medical treatments. Associated features were identified, including age, a BDD diagnosis, body dysmorphic symptom severity, a likely major depressive disorder, prior cosmetic surgery, and insight. Conclusions: The results of this largest study to date highlight that BDD is still underrecognized and undertreated even in a country with extensive mental health care and few financial barriers. We discuss modifiable factors and strategies to foster awareness of BDD in sufferers and professionals to improve treatment dissemination and to reduce treatment barriers.
Overview
CoChat Summary
## TL;DR
This online survey study of 429 German-speaking individuals who met DSM-5 criteria for BDD found low rates of diagnosis and treatment use despite substantial symptom burden. Treatment barriers were common, especially shame, low perceived need, and preference for cosmetic/medical help.
## Key findings
- Only 15.2% (n = 65) of the 429 participants had been diagnosed with BDD by a professional, and 39.9% (n = 171) reported any lifetime mental health treatment for appearance concerns.
- 22.1% (n = 95) were currently receiving psychopharmacological and/or psychological treatment for appearance concerns, and among these, only 42.1% (n = 40) had been diagnosed with BDD.
- Common barriers included shame, low perceived need, and a preference for cosmetic/medical treatments; the paper also notes that 28.2% each reported uncertainty about finding the appropriate provider and preference for cosmetic/medical treatments.
- In correlational analyses, treated individuals were older, more often had a BDD diagnosis, had higher symptom severity, and more often screened positive for current major depressive disorder; among those with prior psychiatric inpatient care, 18.5% (n = 10) had a past suicide attempt versus 5.33% (n = 20) among those never hospitalized (Χ²(1, 429) = 12.62, p < .001, V = .17).
## Methods
- Cross-sectional anonymous online self-report survey on appearance concerns conducted in Germany; the final sample included N = 429 German-speaking participants meeting DSM-5 criteria for BDD.
- Measures included self-reported DSM-5 BDD screening items, the SCOFF for eating disorders, the FKS for BDD symptom severity/insight/cosmetic surgery/suicide attempts, the PHQ-9 for likely major depressive disorder, a treatment history questionnaire, and a modified Barriers to Treatment Questionnaire.
- Analyses were descriptive plus group comparisons and regressions: t-tests, chi-square tests, Fisher’s exact test where needed, and hierarchical logistic regression / multiple regression with Bonferroni correction for multiple comparisons.
## Limitations
- The paper states that the study is cross-sectional, so it cannot support causal inference.
- Because participants were identified through an online self-report format, they were not diagnosed by trained professionals; the authors note that other disorders or medical conditions could better explain some reported symptoms, and that the self-report BDD measure had not been validated thoroughly.
- The sample was self-selected and recruited via a clinic website, limiting generalizability; this is an evident limitation from the text and may mean the sample was more treatment-aware than the broader BDD population.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 1 Not valid · 32 Not checked · 108 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“awareness for BDD is still lower than for other, comparably less common mental disorders like anorexia nervosa or schizophrenia.”
§ Treatment utilization and treatment barriers in individuals with body dysmorphic disorder > Background
What the sources say
- Partly supportedcites [9] Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image. 2016;18:168–86. sourceExperimental — accuracy not yet measured
Our copy supports the two component facts the sentence rests on but not the comparison it draws: the Conclusions state 'There is still a low level of awareness and understanding about BDD amongst the public and health professionals', and the Discussion (p. 22) states BDD is more common in the community than anorexia nervosa (0.3%) and schizophrenia (0.5%), which is why those disorders are described as 'comparably less common'. However, no passage compares awareness of BDD with awareness of anorexia nervosa or schizophrenia — the paper never says BDD awareness is lower than that for other disorders, only that it is low in absolute terms and that BDD remains 'hidden'. The relative-awareness claim attributed to this source is therefore unsupported. (LLM, conf=0.72)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“First, feelings of shame are strongly associated with BDD [19]”
§ Treatment utilization and treatment barriers in individuals with body dysmorphic disorder > Background
What the sources say
- Supportedcites [19] Weingarden H, Renshaw KD. Shame in the obsessive compulsive related disorders: a conceptual review. J Affect Disord. 2015;171:74–84. source
The Results section (‘Shame in BDD’) describes shame as central to BDD and reports that a BDD group had greater general and body shame than healthy controls, with large effects. This supports the broad claim that shame is strongly associated with BDD. (LLM, conf=0.92)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Therefore, many of them choose cosmetic treatments [9] over psychological interventions.”
§ Treatment utilization and treatment barriers in individuals with body dysmorphic disorder > Background
What the sources say
- Supportedcites [9] Veale D, Gledhill LJ, Christodoulou P, Hodsoll J. Body dysmorphic disorder in different settings: a systematic review and estimated weighted prevalence. Body Image. 2016;18:168–86. source
The Abstract (p. 1) states that 'many resources are wasted on those with BDD who attend dermatological or cosmetic surgery settings in an attempt to fix their imagined defect and receive physical treatments instead of the psychiatric help they actually need,' and the Conclusions section repeats that when people with BDD seek help they are 'more likely to present in a dermatological, cosmetic or orthognathic setting than a psychiatric one' (prevalence 9.2-20.1% in those settings vs 7.4% in psychiatric ones). The Cosmetic Settings section likewise documents the highest weighted prevalence in cosmetic surgery clinics (13.2%), confirming the pattern the citing sentence attributes. The source frames this as help-seeking driven by shame and poor detection rather than an informed 'choice', but the substance of the claim is stated. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This may reflect a low perceived need for treatment that was already found as a major treatment barrier for other severe mental disorders in the worldwide WHO World Mental Health Surveys [47].”
§ Treatment utilization and treatment barriers in individuals with body dysmorphic disorder > Discussion
What the sources say
- Supportedcites [47] Andrade LH, Alonso J, Mneimneh Z, Wells JE, Al-Hamzawi A, Borges G, et al. Barriers to mental health treatment: results from the WHO world mental health surveys. Psychol Med. 2014;44:1303–17. source
The Results ('Barriers to seeking treatment') state that among respondents with serious disorders low perceived need was the most commonly-reported barrier to treatment in 15 of the 25 WMH surveys (99.3-56.4%), and the Discussion (p. ~) asserts that 'low perceived need for treatment is an extremely important barrier for seeking treatment worldwide' and that 'a substantial number of severe cases think that they do not need help'. The Abstract Conclusions likewise name low perceived need a major barrier worldwide. Minor qualification: the paper groups all 12-month DSM-IV disorders together and finds low perceived need somewhat less prevalent among severe than mild/moderate cases (structural barriers dominating for severe cases), and it did not assess disorders such as schizophrenia. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most participants reported shame, stigma, and discrimination barriers, which is consistent with prior research on BDD [10, 16, 17, 19] and mental health problems [45].”
§ Treatment utilization and treatment barriers in individuals with body dysmorphic disorder > Discussion
What the sources say
- Not checked yetcites [10] Veale D, Akyüz EU, Hodsoll J. Prevalence of body dysmorphic disorder on a psychiatric inpatient ward and the value of a screening question. Psychiatry Res. 2015;230:383–6. source
- Not checked yetcites [16] Buhlmann U. Treatment barriers for individuals with body Dysmorphic disorder: an internet survey. J Nerv Ment Dis. 2011;199:268–71. source
- Not checked yetcites [17] Marques L, Weingarden HM, LeBlanc NJ, Wilhelm S. Treatment utilization and barriers to treatment engagement among people with body dysmorphic symptoms. J Psychosom Res. 2011;70:286–93. source
- Partly supportedcites [19] Weingarden H, Renshaw KD. Shame in the obsessive compulsive related disorders: a conceptual review. J Affect Disord. 2015;171:74–84. sourceExperimental — accuracy not yet measured
In the Results section 'Shame in BDD > Shame as a treatment barrier' (p. ~5), Weingarden and Renshaw do review prior BDD research showing shame as a barrier to disclosure and treatment: 50% of 172 individuals with BDD endorsed 'I am too ashamed to talk about my appearance concerns' (Buhlmann, 2011) and 55.6% of 401 participants endorsed shame as a treatment barrier (Marques et al., 2011), which the authors summarize as 'approximately half of those with BDD avoid treatment due to shame' — not 'most participants'. The same section and the Discussion treat only shame (general, body, and shame about having a mental illness); our copy contains no discussion of stigma or discrimination as reported barriers, so those parts of the claim are not supported by this source. (LLM, conf=0.78)
- Not checked yetcites [45] Corrigan P. How stigma interferes with mental health care. Am Psychol. 2004;59:614–25. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
93 more claims
Create a free account to see all 147 claims and to verify the 59 references still open.
- It may state two separate claims as one. 29
- Probably not a substantial claim. 26
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Bár a BDD-t már több mint 130 éve leírta egy olasz pszichiáter (Morselli, 1891), a betegséget mind a mai napig ritkán ismerik fel, és a betegek jelent ő s része ellátatlan marad (Borda, Neziroglu, Santos, Donnelly és Perez Rivera, 2011; Schulte, Schulz, Wilhelm és Buhlmann, 2020).”
From A testdiszmorfiás zavar pszichológiai vonatkozásai (2023) · cites this paper as Schulte, Schulz, Wilhelm és Buhlmann, 2020
The cited source says what the claim attributes to it.
In the citing paper
“awareness of BDD remains poor”
From Access to evidence-based treatments for young people with body dysmorphic disorder (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“the condition often goes undiagnosed and untreated”
From Access to evidence-based treatments for young people with body dysmorphic disorder (2023) · cites this paper as [1]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802 · cited 2×
“The Patient’s Health Questionnaire depression scale (PHQ-9) [33, 34] is a 9-item questionnaire assessing depression symptoms in the past 2 weeks on a 4-point Likert scale (0 = “not at all”, 1 = “several days”, 2 = “more than half the days”, 3 = “nearly every day”).”
BackgroundHow stigma interferes with mental health care.
Corrigan, P. (2004) · American Psychologist · doi:10.1037/0003-066x.59.7.614 · Cited by 3,648 · cited 1×
“Most participants reported shame, stigma, and discrimination barriers, which is consistent with prior research on BDD [10, 16, 17, 19] and mental health problems [45].”
ResultTangney, J. P., & Dearing, R. L. (2002) · Medical Entomology and Zoology · Cited by 2,063
The SCOFF questionnaire: Assessment of a new screening tool for eating disorders
Morgan, J. F., Reid, F., & Lacey, J. H. (1999) · BMJ · doi:10.1136/bmj.319.7223.1467 · Cited by 1,416 · cited 1×
“To further screen for possible comorbid eating disorders, participants completed the SCOFF questionnaire [29, 30] by indicating “yes” or “no” on five items on disordered eating (e.”
BackgroundBarriers to mental health treatment: results from the WHO World Mental Health surveys
Andrade, L. H., Alonso, J., Mneimneh, Z., Wells, J. E., Al-Hamzawi, A., Borges, G., Bromet, E., Bruffaerts, R., de Girolamo, G., de Graaf, R., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291713001943 · Cited by 1,289 · cited 1×
“This may reflect a low perceived need for treatment that was already found as a major treatment barrier for other severe mental disorders in the worldwide WHO World Mental Health Surveys [47].”
BackgroundMünster, R. D. (1999) · Zeitschrift für Klinische Psychologie und Psychotherapie · doi:10.1026//0084-5345.28.1.68 · Cited by 1,010
Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)“
Gräfe, K., Zipfel, S., Herzog, W., & Löwe, B. (2004) · Diagnostica · doi:10.1026/0012-1924.50.4.171 · Cited by 801
Phillips, K. A., Menard, W., Fay, C., & Weisberg, R. (2005) · Psychosomatics · doi:10.1176/appi.psy.46.4.317 · Cited by 545 · cited 2×
“[22] compared currently treated and untreated individuals with diagnosed BDD and found that those in treatment had a higher lifetime comorbidity for any mood disorder, OCD and eating disorders.”
Background(2005) · Oxford University Press eBooks · Cited by 499
Research works printed but not linked: 6
- Questback GmbH. EFS survey, version summer 2017. Questback GmbH: Cologne; 2017.
- Wittchen HU, Zaudig M, Fydrich T. Strukturiertes klinisches interview für DSM-IV: SKID [structured clinical interview for DSM-IV (SCID)]. Hogrefe Verlag: Göttingen; 1997.
- Löwe B, Spitzer R, Zipfel S, Herzog W. Gesundheitsfragebogen für Patienten. Autorisierte deutsche version des Prime MD patient health questionnaire (PHQ-D) [the patient health questionnaire. Authorized German version of the Prime MD patient health questionnaire (PHQ-D)]. 2nd edition. Karlsruhe: Pfizer; 2002.
- Wilhelm S, Phillips KA, Steketee G. A cognitive behavioral treatment manual for body dysmorphic disorder. New York: Guilford Press; 2013.
- Phillips KA. Differentiating body Dysmorphic disorder from Normal appearance concerns and other mental disorders. In: Phillips KA, editor. Body dysmorphic disorder: advances in research and clinical practice. New York: Oxford University Press; 2017. p. 227–39.
- Phillips KA. Assessment of body Dysmorphic disorder: screening, diagnosis, severity, and insight. In: Phillips KA, editor. Body Dysmorphic disorder - advances in research and clinical practice. 1st ed. New York City: Oxford University Press; 2017. p. 205–25.
Cited by
Future of Mental Health in the Metaverse
Usmani, S. S., Sharath, M., & Mehendale, M. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100825 · Cited by 262
Seiferth, C., Vogel, L., Aas, B., Brandhorst, I., Carlbring, P., Conzelmann, A., Esfandiari, N., Finkbeiner, M., Hollmann, K., Lautenbacher, H., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00085-1 · Cited by 121
“These challenges include health disparities, insufficient infrastructure, workforce shortage, long waiting lists 2 , stigmatization and low perceived need 3 .”
BackgroundWilhelm, S., Weingarden, H., Greenberg, J. L., Hoeppner, S. S., Snorrason, I., Bernstein, E. E., McCoy, T. H., & Harrison, O. T. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524628 · Cited by 72
“Despite its strong evidence base, most patients do not receive CBT [7, 8].”
BackgroundSelf-citationPrevalence of body dysmorphic disorder: A systematic review and meta-analysis
McGrath, L. R., Oey, L. T., McDonald, S., Berle, D., & Wootton, B. M. (2023) · Body Image · doi:10.1016/j.bodyim.2023.06.008 · Cited by 81
Zhao, F., Guo, Z., Yan, B., Feng, L., & Zhao, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.004 · Cited by 54
Metadata
- Authors
- Schulte, J., Schulz, C., Wilhelm, S., & Buhlmann, U.
- Affiliations
- University of Münster (DE)
- Harvard University (US)
- Corresponding author
- Buhlmann, Ulrike
- Venue
- BMC Psychiatry
- Published
- 2020-02-18
- Volume
- 20
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC7027080
- OpenAlex
- W3010695255
- Cited by
- 97
- References
- 52
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 26 · 2023: 14 · 2022: 12 · 2021: 9 · 2020: 5
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Westfälische Wilhelms-Universität Münster
- Topics
- Social Sciences › Psychology › Clinical Psychology › Body Image and Dysmorphia Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- body dysmorphic disorder, treatment utilization, barriers to treatment, psychotherapy, shame, perceived need, cosmetic surgery, major depressive disorder, insight, treatment dissemination
- MeSH terms
- Adolescent, Adult, Aged, Major Depressive Disorder, Depressive Disorder, Major, Female, Germany, Humans, Male, Middle Aged, Surveys and Questionnaires, Prevalence, Young Adult, Body Dysmorphic Disorders, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment utilization and treatment barriers in individuals with body dysmorphic disorder. https://app.cochat.ai/papers/10.1186/s12888-020-02489-0
- The paper
- Schulte, J., Schulz, C., Wilhelm, S., & Buhlmann, U. (2020). Treatment utilization and treatment barriers in individuals with body dysmorphic disorder. BMC Psychiatry. https://doi.org/10.1186/s12888-020-02489-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.